Since the AT-II/AT1R axis plays a key role in tumor angiogenesis, we focused on the impact of losartan on the changes in HCC angiogenic status and its interaction with lenvatinib-mediated angiogenic activity. Here, AGTR1 is linked to hepatocellular carcinoma.